Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 5.95% is 223% above its 5-year average of -4.84%, around the middle of its 5-year range (-24.52%–24.52%).
101.00% above its 12-month average of 2.96%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.56%.
OPERATING MARGIN
5.95%
OPERATING MARGIN AVG TTM
2.96%
OPERATING MARGIN AVG 3Y
-1.22%
OPERATING MARGIN AVG 5Y
-4.84%
OPERATING MARGIN AVG 10Y
-8.20%
OPERATING MARGIN AVG 15Y
-14.37%
OPERATING MARGIN AVG 20Y
-591.32%
CURRENT VS TTM AVG
+101.00%
CURRENT VS 3Y AVG
+587.84%
CURRENT VS 5Y AVG
+222.93%
CURRENT VS 10Y AVG
+172.56%
CURRENT VS 15Y AVG
+141.41%
CURRENT VS 20Y AVG
+101.01%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Vericel Corporation
Market Cap
$2.05B
Operating Margin
5.95%
TTM Avg
2.96%
3Y Avg
-1.22%
5Y Avg
-4.84%
Market Cap
$2.06B
Operating Margin
-512.91%
TTM Avg
-49765.56%
3Y Avg
-47036.35%
5Y Avg
-33558.09%
Market Cap
$2.07B
Operating Margin
-19160.00%
TTM Avg
-10969.44%
3Y Avg
-7268.29%
5Y Avg
-5243.17%
Market Cap
$2.01B
Operating Margin
38.98%
TTM Avg
19.21%
3Y Avg
-11.92%
5Y Avg
-190.31%
Market Cap
$2.02B
Operating Margin
37.06%
TTM Avg
17.54%
3Y Avg
-25.09%
5Y Avg
-117.46%
Market Cap
$2.01B
Operating Margin
-113.73%
TTM Avg
-110.40%
3Y Avg
-105.71%
5Y Avg
-281.52%
Market Cap
$2.10B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Vericel Corporation (VCEL) | $2.05B | 5.95% | 2.96% | -1.22% | -4.84% |
| Viridian Therapeutics, Inc. (VRDN)vs › | $2.06B | -512.91% | -49765.56% | -47036.35% | -33558.09% |
| Progyny, Inc. (PGNY)vs › | $2.03B | 8.55% | 6.20% | 5.27% | 4.99% |
| Celldex Therapeutics, Inc. (CLDX)vs › | $2.07B | -19160.00% | -10969.44% | -7268.29% | -5243.17% |
| Alvotech (ALVO)vs › | $2.08B | 9.62% | 13.78% | -194.45% | -270.76% |
| BioCryst Pharmaceuticals, Inc. (BCRX)vs › | $2.01B | 38.98% | 19.21% | -11.92% | -190.31% |
| Aurinia Pharmaceuticals Inc. (AUPH)vs › | $2.02B | 37.06% | 17.54% | -25.09% | -117.46% |
| UroGen Pharma Ltd. (URGN)vs › | $2.01B | -113.73% | -110.40% | -105.71% | -281.52% |
| Vera Therapeutics, Inc. (VERA)vs › | $2.10B | 0.00% | 0.00% | 0.00% | 0.00% |
| Addus HomeCare Corporation (ADUS)vs › | $2.11B | 10.04% | 9.32% | 8.61% | 7.98% |
Gross Margin
74.6%
Operating Margin
6.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.56% |
| 2026-03-31 | -11.79% |
| 2025-12-31 | 24.12% |
| 2025-09-30 | 5.11% |
| 2025-06-30 | -3.21% |
| 2025-03-31 | -24.32% |
| 2024-12-31 | 24.52% |
| 2024-09-30 | -4.26% |
| 2024-06-30 | -11.45% |
| 2024-03-31 | -10.66% |
| 2023-12-31 | 19.59% |
| 2023-09-30 | -11.09% |
| 2023-06-30 | -12.98% |
| 2023-03-31 | -19.94% |
| 2022-12-31 | 11.55% |
| 2022-09-30 | -17.61% |
| 2022-06-30 | -24.52% |
| 2022-03-31 | -20.16% |
| 2021-12-31 | 8.70% |
| 2021-09-30 | -14.38% |
| 2021-06-30 | -9.44% |
| 2021-03-31 | -9.56% |
| 2020-12-31 | 27.17% |
| 2020-09-30 | 10.90% |
| 2020-06-30 | -41.76% |
| 2020-03-31 | -19.03% |
| 2019-12-31 | 23.38% |
| 2019-09-30 | 10.15% |
| 2019-06-30 | -77.24% |
| 2019-03-31 | -15.40% |
| 2018-12-31 | 19.13% |
| 2018-09-30 | -5.94% |
| 2018-06-30 | -22.33% |
| 2018-03-31 | -23.98% |
| 2017-12-31 | 5.10% |
| 2017-09-30 | -28.27% |
| 2017-06-30 | -14.87% |
| 2017-03-31 | -102.80% |
| 2016-12-31 | -35.64% |
| 2016-09-30 | -58.38% |
| 2016-06-30 | -38.87% |
| 2016-03-31 | -14.12% |
| 2015-12-31 | -32.15% |
| 2015-09-30 | -43.12% |
| 2015-06-30 | -16.67% |
| 2015-03-31 | -42.14% |
| 2014-12-31 | -15.95% |
| 2014-09-30 | -83.06% |
| 2014-06-30 | -192.28% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | -61550.00% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | -174466.67% |
| 2013-03-31 | -89562.50% |
| 2012-12-31 | -40089.47% |
| 2012-09-30 | -92055.56% |
| 2012-06-30 | 0.00% |
| 2012-03-31 | -427900.00% |
| 2011-12-31 | -1554.37% |
| 2011-09-30 | -82655.56% |
| 2011-06-30 | 0.00% |
| 2011-03-31 | -69555.56% |
| 2010-12-31 | 0.00% |
| 2010-09-30 | 0.00% |
| 2010-06-30 | 24476.19% |
| 2010-03-31 | 0.00% |
| 2009-12-31 | -28656.25% |
| 2009-09-30 | -5227.40% |
| 2009-06-30 | -5776.81% |
| 2009-03-31 | -6917.24% |
| 2008-12-31 | -14828.57% |
| 2008-09-30 | -14885.19% |
| 2008-06-30 | -3351.01% |
| 2008-03-31 | -2618.32% |
| 2007-12-31 | -6591.67% |
| 2007-09-30 | -6206.90% |
| 2007-06-30 | -3165.45% |
| 2007-03-31 | -1907.75% |
| 2006-12-31 | -3000.00% |
| 2006-09-30 | -4407.69% |
| 2006-06-30 | -1463.72% |
| 2006-03-31 | -2016.39% |
| 2005-12-31 | -3708.55% |
| 2005-09-30 | -2107.78% |
| 2005-06-30 | -3755.21% |
| 2005-03-31 | -1409.92% |
| 2004-12-31 | -681.82% |
| 2004-09-30 | -1448.66% |
| 2004-06-30 | -1334.76% |
| 2004-03-31 | -607.69% |
| 2003-12-31 | -648.94% |
| 2003-09-30 | -962.00% |
| 2003-06-30 | -1581.71% |
| 2003-03-31 | -756.03% |
| 2002-12-31 | -1356.73% |
| 2002-09-30 | -2680.65% |
